LightArray to Provide Aushon BioSystems' Products and Services in China | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Aushon BioSystems today said that LightArray Biotech will provide the firm's multiplex biomarker products and services in China.

LightArray operates a drug development services lab in Wuxi, China. Aushon said that the firm will offer its biomarker technologies, including more than 300 validated assays, multiplex biomarker sample testing services and kits, custom arrays and assay development, and array imaging and analysis systems.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.